Recital 19, Decision_act (EU) 2025/1074

In forcesince 2 Jun 2025

In conclusion, pursuant to Article 2(2), points (b) and (c), of Regulation (EU) No 528/2012, the use of ethylene oxide included in the application and the additional uses intended to be supported by the applicant for use in biocidal products of product-type 2 are not within the scope of Regulation (EU) No 528/2012, but they are considered within the scope of the Union legislation on medicinal products or Regulation (EU) 2017/745.